Clinical studies recruiting near Pasadena

Studies with at least one listed site matching this location on the public registry. Each page explains the study in plain language, with locations and study-team contacts. Clinicians: generate a printable list for your patient →

This Study Will Explore Whether a Combination of the Investigational Drug Mevrometostat (PF-06821497) and Enzalutamide W
Phase 3 · UCLA Hematology/Oncology - Pasadena · Pfizer · NCT07028853 Filipino Family Health Initiative 1.0
NA · Kaiser Permanente Bernard J. Tyson School of Medicine · Kaiser Permanente · NCT06569303 A Study of Nemtabrutinib (MK-1026) Versus Comparator (Investigator's Choice of Ibrutinib or Acalabrutinib) in First Line
Phase 3 · Care Access - South Pasadena ( Site 0070) · Merck Sharp & Dohme LLC · NCT06136559 Phase III Study of Ivonescimab or Bevacizumab Combined With FOLFOX in Patients With Metastatic Colorectal Cancer
Phase 3 · Clinical Study Site · Summit Therapeutics · NCT07228832 A Study to Assess the Effectiveness and Safety of IPN10200 Over Time in Adults With Moderate to Severe Wrinkle-like Line
Phase 3 · Skin and Beauty Center · Ipsen · NCT07435428 Testing the Safety and Tolerability of the Anti-cancer Drugs Trastuzumab Deruxtecan and Neratinib for Cancers With Chang
Phase 1 · City of Hope South Pasadena · National Cancer Institute (NCI) · NCT05372614 Seladelpar in Subjects With Primary Biliary Cholangitis (PBC) and Compensated Cirrhosis
Phase 3 · California Liver Research Institute · Gilead Sciences · NCT06051617 EASi-KIDNEY™ (The Studies of Heart & Kidney Protection With BI 690517 in Combination With Empagliflozin)
Phase 3 · Renal Specialists of Houston, PA · Boehringer Ingelheim · NCT06531824 Study of Aritinercept in Patients With Generalized Myasthenia Gravis
Phase 1/Phase 2 · Aurinia Investigational Site · Aurinia Pharmaceuticals Inc. · NCT07596901 Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease
Phase 2/Phase 3 · City of Hope South Pasadena · NRG Oncology · NCT05174169 AI-Enabled Direct-from-ECG Ejection Fraction (EF) Severity Assessment Using COR ECG Wearable Monitor
Phase N/A · Peerbridge Health · Peerbridge Health, Inc · NCT06699056 ShortStop-HER2: 12 Months vs. 6 Months of HER2-targeted Medications for People With HER2+ Breast Cancer Who Had a Pathol
Phase 3 · Huntington Memorial Hospital · Alliance for Clinical Trials in Oncology · NCT06876714 A Study Evaluating Disease Characteristics and Outcomes in Participants With Asthma in Routine Clinical Practice
Phase N/A · Pasadena Clinical Trials - Site Number: 840116 · Sanofi · NCT07556159 Stereotactic Radiosurgery Compared With Hippocampal-Avoidant Whole Brain Radiotherapy (HA-WBRT) Plus Memantine for 5 or
Phase 3 · City of Hope South Pasadena · Canadian Cancer Trials Group · NCT03550391 Visuomotor Prosthetic for Paralysis
NA · California Institute of Technology · Richard A. Andersen, PhD · NCT01958086 Testing Early Treatment for Patients With High-Risk Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Leukemia (SL
Phase 3 · City of Hope South Pasadena · National Cancer Institute (NCI) · NCT04269902 Docetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Castration Sensitive Prostate Cancer and S
Phase 3 · Keck Medical Center of USC Pasadena · Canadian Cancer Trials Group · NCT06592924 Motivational Wellness Coaching to Reduce Childhood Obesity in Families and Kids
NA · Kaiser Permanente Pasadena · Kaiser Permanente · NCT05143697 Ultra-hypofractionated Whole Breast Irradiation With Lumpectomy Cavity Boost for the Treatment of Stage I-III Breast Can
Phase 2 · City of Hope South Pasadena · City of Hope Medical Center · NCT06954831 A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight and Type
Phase 3 · HRI ? Pasadena, LLC · Hoffmann-La Roche · NCT07351058 A Study to Evaluate the Efficacy and Safety of Intravenous (IV) Prasinezumab in Participants With Early-Stage Parkinson'
Phase 3 · Profound Research LLC at The Neurology Center of Southern Ca · Hoffmann-La Roche · NCT07174310 A Study Evaluating Efruxifermin in Subjects With Compensated Cirrhosis Due to NASH/MASH
Phase 3 · Akero Clinical Study Site · Akero Therapeutics, Inc · NCT06528314 A Phase 3 Study to Evaluate the Efficacy and Safety of Intravitreal KSI-101 in Participants With Macular Edema Secondary
Phase 3 · California Eye Specialists Medical Group, Inc. · Kodiak Sciences Inc · NCT06990399 Adjuvant Therapy in POLE-Mutated and p53-Wildtype/NSMP Early Stage Endometrial Cancer RAINBO BLUE & TAPER
Phase 2 · Huntington Memorial Hospital · Canadian Cancer Trials Group · NCT05640999 Provider Recommendation and HPV Vaccination
NA · Kaiser Permanente Southern California · Kaiser Permanente · NCT05365048 A Phase IIb Study to Evaluate the Effect of Dapagliflozin in Combination With Baxdrostat Compared With Baxdrostat on Alb
Phase 2 · Research Site · AstraZeneca · NCT07222917 A Study to Evaluate the Efficacy and Safety of Pegozafermin in Participants With Compensated Cirrhosis Due to MASH
Phase 3 · 89bio Clinical Study Site · 89bio, Inc. · NCT06419374 Open-Label Extension Study to Assess the Long-Term Safety and Tolerability of KarXT in Subjects With Psychosis Associate
Phase 3 · SC3 Research - Pasadena - 960 E. Green St · Karuna Therapeutics, Inc., a Bristol Myers Squibb company · NCT05980949 Combining Immunotherapy and Radiation Therapy to Help Patients Avoid Bladder Removal After Treatment Shrinks Muscle Inva
Phase 2 · City of Hope South Pasadena · National Cancer Institute (NCI) · NCT07061964 A Phase 3 Study to Evaluate the Safety and Efficacy of KarXT + KarX-EC for the Treatment of Agitation Associated With Al
Phase 3 · Local Institution - 2613 · Bristol-Myers Squibb · NCT07011745

Look up another city

Look up another condition